Scientific Advisory Board
Aspect Imaging’s Scientific Advisory Board is comprised of world-class researchers
and imaging experts who serves as an advisory group to the company regarding its
research and development projects.
|
Robert Lenkinski, Ph.D
Co-Director, Longwood Small Animal Imaging Facility,
Beth Israel Deaconess Medical Center, Boston, MA
Professor of Radiology, Beth Israel Deaconess
and Harvard University
Dr. Lenkinski is a Professor of Radiology at Harvard Medical School, a Vice-Chairman and Director of
Radiology Research at Beth Israel Deaconess Medical Center, and Co-Director, Longwood Small Animal
Imaging Facility. One of his major research interests is the clinical applications of in vivo Magnetic
Resonance spectroscopy. Dr Lenkinski is also developing in vivo multinuclear MR imaging methods. A more
recent area of interest has been molecular imaging. He received his Ph.D in Chemistry from the University
of Houston. He has authored many articles in peer-reviewed journals and has been awarded several patents.
View Dr. Lenkinski’s publications on:
|
|
Allan G. Johnson, Ph.D
Director, Center for In Vivo Microscopy
Charles E. Putman Distinguished Professor of Radiology,
Professor of Biomedical Engineering and Physics
Duke University, NC
Dr. Johnson is Director of the Center for In Vivo Microscopy, an NIH/NCRR National Biomedical
Technology Resource Center. He received his PhD in Physics from Duke University in 1974 in electron
spin resonance under Professor Walter Gordy. He was responsible for installing the first CT system
at Duke in 1974 (the 2nd CT system in the US). From 1981-83 he worked with GE to install the world’s
first high field (1.5T) clinical MRI system. He holds appointments in Radiology, Physics, and Biomedical
Engineering as the Charles E. Putman University Professor. He is co-author on more than 250 peer-reviewed
papers. Dr. Johnson is the principal investigator of the Duke Molecular Imaging Center supported by the
National Cancer Institute to develop new imaging strategies for the detection and characterization of
cancer and the application of those techniques in preclinical studies. He is also a principal investigator
in the Mouse Biomedical Informatics Research Network (MBIRN), a multi-institutional collaboration that
integrates studies in the mouse from millimeter to submicron resolution. Dr. Johnson’s personal research is
in magnetic resonance histology (MRH), the application of MR microscopy to the study of tissue architecture.
The use of MRH for morphologic phenotyping in the mouse was first suggested by Dr. Johnson and his colleagues
in 1993. More recently MRH has been extended to 21 microns in the mouse brain for high throughput phenotyping.
Dr. Johnson and his team are currently focused on extending the technology to achieve spatial resolution
approaching the theoretical limit of ~10 microns.
View Dr. Johnson’s publications on:
|
|
Peter Bendel, Ph.D
Senior Staff Scientist,
Director, NMR and MRI Facilities,
Department of Chemical Research Support
Weizmann Institute of Science, Israel
Dr. Bendel is a Senior Staff Researcher at the Weizmann Institute of Science, where he supervises
the NMR and MRI facilities
in the Department of Chemical Research Support. He has over 30 years’ of
experience in the field of MRI, including having worked as R & D Physicist at Elscint, as a Visiting
Scientist at the University of Tennessee Medical Center, and in the Corporate Research Laboratory of
ExxonMobil.
View Dr. Bendel’s publications on:
|
|
Gil Navon, Ph.D
Professor Emeritus,
Tel Aviv University, Tel Aviv, Israel
Dr. Navon is an Active Professor Emeritus of Chemistry at Tel Aviv University. He has contributed
to the field of biomedical NMR from its beginning. He has achieved many original breakthroughs
including the first 31P NMR of live cancer and bacterial cells, multiple quantum NMR of 23Na in
perfused rat hearts and cartilage, MRI of electrical currents, parallel MRI with coil arrays,
indirect detection of H217O, SPINOE and DQF NMR and MRI of connective tissues and nerves. He is
co-author on more than 250 peer-reviewed papers and has been awarded 12 patents.
View Dr. Navon’s publications on:
|